Benralizumab - 2 mg

Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma.1

Supplier Catalog Number

 82843-2

Shipping conditions

 Room temperature

Storage Temperature

 +4°C

Supplier name

 BPS Bioscience
From
€3,081.00
Total €3,081.00

No surprise after checkout. All fees included

Your satisfaction first: door delivery with guaranteed replacement

Dedicated Scientific Support to select & use